A Study to Assess the Safety, Tolerability, and Efficacy of BIVV003 for Autologous Hematopoietic Stem Cell Transplantation in Patients With Severe Sickle Cell Disease
PHASE1
This is an open label, multicenter, Phase 1/2 study in approximately eight ...
Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
NA
RATIONALE: Giving chemotherapy and total-body irradiation (TBI) before a do...
Status
Terminated
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium